Patient-centered context on treatment goals, care layers, biologics, surgery, and questions for dermatology visits.
Treatment for Acne Inversa, also called Hidradenitis Suppurativa (HS), is rarely a single product or quick fix. It is usually a plan: reduce active inflammation, manage pain and drainage, protect daily life, and decide when structural damage needs a procedural or surgical answer.
This page is written as orientation for patients and caregivers. It can help you understand the main treatment conversations, but it cannot tell you which option is right for your body, your risks, or your medical history.
A good HS treatment conversation starts with goals. Some therapies aim to calm active inflammatory lesions. Others help with infection control, wound care, pain, or odor. Procedures and surgery may be discussed when tunnels, scarring, or recurring lesions have become structural problems.
Current guideline thinking separates the active inflammatory part of HS from the more structural, non-inflammatory damage. That matters because medication may reduce inflammation, while established tunnels or scarred tissue may need a different approach.
Fewer painful nodules, abscesses, and draining lesions
Less pain, odor, leakage, and disruption to everyday life
Prevention of progression where possible
Clear next steps if the current plan is not working
Why severity and location matter
HS can look very different from one person to another. A person with a few recurring nodules in one area needs a different discussion than someone with multiple body areas, draining tunnels, or repeated procedures.
Dermatologists often consider the number and type of lesions, affected body regions, pain, drainage, scarring, previous treatments, comorbidities, pregnancy plans, infection risk, and the impact on work, movement, sleep, and mental health.
Treatment usually combines several layers
Many people need more than one layer of care. A plan might include skin and wound-care routines, medicines used during flares, longer-term anti-inflammatory treatment, procedures for persistent lesions, and support for pain or emotional burden.
The practical question is not simply 'Which treatment is best?' but 'Which combination fits the current form of my HS, my risk profile, and my goals?'
Understanding options
Possible layers of care
The options below are not a ladder to follow on your own. They are the main categories patients may hear about in dermatology appointments.
Skin care, friction reduction, and wound care
Gentle cleansing, dressings, odor control, drainage management, and reducing avoidable friction can make daily life more manageable.
Appointment prompt: Ask which products are worth using, which may irritate your skin, and what to do when wounds drain heavily or do not heal.
Topical and local treatments
Topical antibiotics, antiseptic washes, resorcinol, or corticosteroid injections may be discussed for selected mild or localized situations.
Appointment prompt: Ask what the treatment is meant to improve, how long to try it, and when to call if a painful lesion worsens.
Oral medicines
Oral antibiotics are often used because they can reduce inflammation as well as bacteria. Hormonal approaches may be relevant for some patients.
Appointment prompt: Ask about treatment duration, side effects, interactions, pregnancy considerations, and what happens if symptoms return after stopping.
Biologics and biosimilars
For moderate-to-severe inflammatory HS, biologic medicines may be considered. They target parts of the immune system involved in inflammation.
Appointment prompt: Ask about eligibility, screening before treatment, infection risks, vaccination timing, monitoring, access, and realistic timelines.
Procedures and surgery
Procedures may help with individual painful lesions, recurring abscesses, tunnels, or scarred areas. Surgery is often about removing structural disease, not simply 'draining' a flare.
Appointment prompt: Ask whether the goal is temporary relief, deroofing, excision, laser treatment, or long-term control in a specific area.
Pain, mental health, and comorbidity support
HS pain, sleep disruption, anxiety, depression, metabolic health, inflammatory bowel symptoms, and joint symptoms may all matter to care.
Appointment prompt: Ask which symptoms should trigger referral to another specialist and how pain can be addressed without relying on guesswork.
Biologics
Understanding biologics neutrally
Biologic approvals and availability differ by country. In Europe and the United States, the main approved biologic options for HS now include adalimumab, secukinumab, and bimekizumab, with age indications and access rules varying by region.
Adalimumab
TNF-alpha inhibitor
The first biologic approved specifically for moderate-to-severe HS. Biosimilars may be available depending on country and insurer.
Secukinumab
IL-17A inhibitor
A biologic option for moderate-to-severe HS. Current U.S. labeling includes adults and pediatric patients 12 years and older.
Bimekizumab
IL-17A and IL-17F inhibitor
A biologic option for adults with moderate-to-severe HS. It targets two IL-17 pathways involved in inflammation.
Questions to bring to your dermatologist
Which part of my HS is active inflammation, and which part is scarring or tunnels?
What is the main goal of the treatment you are proposing?
How will we measure whether this plan is working?
How long should I try this before reassessing?
What side effects, warning signs, or interactions should I know about?
Would wound care, pain support, or surgery change the plan?
What is the next step if this approach is not enough?
When treatment questions should not wait
Seek prompt medical care for fever, rapidly spreading redness, severe worsening pain, confusion, feeling very unwell, or a wound that is spreading or not healing.
If you are using an immune-modifying medicine, ask your clinician in advance which symptoms should lead you to pause, call, or seek urgent care.
Do not start, stop, or combine prescription HS treatments based only on online information.
This website uses analytics services (Vercel Analytics, Speed Insights) to understand how content is used. Your consent is voluntary and can be withdrawn at any time. See our Cookie Policy.
